pAAV-CAG-eYFP Citations (3)
Originally described in: Systemic AAV vectors for widespread and targeted gene delivery in rodents.Challis RC, Ravindra Kumar S, Chan KY, Challis C, Beadle K, Jang MJ, Kim HM, Rajendran PS, Tompkins JD, Shivkumar K, Deverman BE, Gradinaru V Nat Protoc. 2019 Feb;14(2):379-414. doi: 10.1038/s41596-018-0097-3. PubMed Journal
Articles Citing pAAV-CAG-eYFP
Articles |
---|
Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types.
Ravindra Kumar S, Miles TF, Chen X, Brown D, Dobreva T, Huang Q, Ding X, Luo Y, Einarsson PH, Greenbaum A, Jang MJ, Deverman BE, Gradinaru V.
Nat Methods. 2020 May;17(5):541-550. doi: 10.1038/s41592-020-0799-7. Epub 2020 Apr 20.
PubMed
Associated Plasmids |
Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy. Nguyen HX, Wu T, Needs D, Zhang H, Perelli RM, DeLuca S, Yang R, Tian M, Landstrom AP, Henriquez C, Bursac N. Nat Commun. 2022 Feb 2;13(1):620. doi: 10.1038/s41467-022-28251-6. PubMed |
A custom-made AAV1 variant (AAV1-T593K) enables efficient transduction of Japanese quail neurons in vitro and in vivo. Zoabi S, Andreyanov M, Heinrich R, Ron S, Carmi I, Gutfreund Y, Berlin S. Commun Biol. 2023 Mar 28;6(1):337. doi: 10.1038/s42003-023-04712-6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.